Patents by Inventor Richard Green

Richard Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210115445
    Abstract: The inventions relate to compositions and articles of manufacture comprising connexin modulators, pannexin modulators, gap junction modulators, hemichannel modulators, and pannexin channel modulators and their use, alone or in combination, in treating ocular and other disorders.
    Type: Application
    Filed: December 11, 2020
    Publication date: April 22, 2021
    Inventors: Colin Richard GREEN, Yeri KIM, Anthony PHILLIPS, Bradford James DUFT
  • Patent number: 10986561
    Abstract: This disclosure provides systems, methods, and apparatus, including computer programs encoded on computer-readable media, for managing wireless local area network (WLAN) density. The WLAN density is managed to limit how many APs can utilize a first portion of a first frequency band in a geographical area. A limit of APs may be based on an estimated amount of interference that would be caused by the APs to an incumbent system that also uses the first portion of the frequency band. The WLAN density control may prevent the estimated amount of interference caused by APs in a geographical area from exceeding a threshold interference level based on the presence of the incumbent system. WLAN density control may involve the AP configuration of a first AP or may involve the density of client devices associated with one or more APs in the geographical area.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: April 20, 2021
    Assignee: QUALCOMM Incorporated
    Inventors: Hemish Parikh, Tevfik Yucek, Michael Richard Green
  • Publication number: 20210106770
    Abstract: An apparatus having an outer wall that encompasses an interior chamber that holds a predetermined volume of fluid and gas where the gas rises to one end of the interior chamber and the fluid flows to the other end of the interior chamber. The apparatus also has an inlet port that allows for fluid to ingress into the interior chamber and an outlet port that allows for fluid to egress out of the interior chamber.
    Type: Application
    Filed: December 21, 2020
    Publication date: April 15, 2021
    Inventors: Norton Herrick, David Salof, Richard Green
  • Publication number: 20210106769
    Abstract: An air removal device for an intravenous fluid system includes a housing with an inlet for fluid communication with a fluid source, a fluid outlet for fluid communication with a blood vessel of a patient, and an air outlet. The air removal device further includes a disrupting element disposed within the housing in a flow path between the inlet and the fluid outlet, and an air chamber in fluid communication with the air outlet. The disrupting element includes a protrusion extending across the flow path. The flow path includes a first cross-sectional flow area at the inlet, and a second cross-sectional flow area at the protrusion. The second cross-sectional flow area is smaller than the first cross-sectional flow area.
    Type: Application
    Filed: December 20, 2020
    Publication date: April 15, 2021
    Inventors: Norton Herrick, David Saloff, Richard Green
  • Publication number: 20210107963
    Abstract: The present invention provides novels method of targeting delivery of a compound to hypoxic cells, for example treatment of diseases and disorders associated with hypoxia, comprising administration of a construct comprising a targeting carrier peptide and a compound for delivery to a hypoxic cell. The invention also provides novel methods for the treatment of diseases or disorders of the eye by administration of a novel construct, a nucleic acid encoding a novel construct, and/or a nucleic acid vector comprising a nucleic acid encoding a novel construct. The invention further provides novel constructs, nucleic acids encoding such constructs, and/or nucleic acid vectors comprising nucleic acids encoding such constructs.
    Type: Application
    Filed: April 30, 2018
    Publication date: April 15, 2021
    Inventors: Colin Richard GREEN, Frazer Paul COUTINHO, llva Dana RUPENTHAL
  • Publication number: 20210087182
    Abstract: The present invention relates to pharmaceutical agents of formula (I) useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-KB-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
    Type: Application
    Filed: January 20, 2017
    Publication date: March 25, 2021
    Inventors: Ian STANSFIELD, Olivier Alexis Georges QUEROLLE, Virginie Sophie PONCELET, Gerhard Max GROSS, Edgar JACOBY, Lieven MEERPOEL, Janusz Jozef KULAGOWSKI, Calum MACLEOD, Samuel Edward MANN, Simon Richard GREEN, George HYND
  • Publication number: 20210079396
    Abstract: Methods and compositions for modulating the activities of connexins are provided, including, for example, for use in post-surgical, trauma, or tissue engineering applications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated diseases and disorders where localized disruption in direct cell-cell communication is desirable.
    Type: Application
    Filed: September 25, 2020
    Publication date: March 18, 2021
    Inventors: Wilda LAUX, Colin Richard GREEN
  • Publication number: 20210032267
    Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
    Type: Application
    Filed: February 6, 2020
    Publication date: February 4, 2021
    Inventors: Ian Stansfield, Olivier Alexis Georges Querolle, Yannick Aime Eddy Ligny, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Simon Richard Green, George Hynd, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann
  • Publication number: 20210000911
    Abstract: The inventions relate to the use of hemichannel blockers to modulate BRB integrity and function, RPE integrity and function, tight junction integrity and function, ZO-1 internalization, gap junction internalization, and/or type IV collagen levels in a subject.
    Type: Application
    Filed: April 23, 2020
    Publication date: January 7, 2021
    Inventors: Odunayo Omolola Boluwarin MUGISHO, Colin Richard GREEN, Bradford James DUFT
  • Patent number: 10874806
    Abstract: An apparatus having an outer wall that encompasses an interior chamber that holds a predetermined volume of fluid and gas where the gas rises to one end of the interior chamber and the fluid flows to the other end of the interior chamber. The apparatus also has an inlet port that allows for fluid to ingress into the interior chamber and an outlet port that allows for fluid to egress out of the interior chamber.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: December 29, 2020
    Assignee: AILNH, LLC
    Inventors: Norton Herrick, David Saloff, Richard Green
  • Patent number: 10874805
    Abstract: An apparatus having an outer wall that encompasses an interior chamber that holds a predetermined volume of fluid and gas where the gas rises to one end of the interior chamber and the fluid flows to the other end of the interior chamber. The apparatus also has an inlet port that allows for fluid to ingress into the interior chamber and an outlet port that allows for fluid to egress out of the interior chamber.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: December 29, 2020
    Assignee: AILNH, LLC
    Inventors: Norton Herrick, David Saloff, Richard Green
  • Patent number: 10869972
    Abstract: An air removal device for an intravenous fluid system includes a housing with an inlet for fluid communication with a fluid source, a fluid outlet for fluid communication with a blood vessel of a patient, and an air outlet. The air removal device further includes a disrupting element disposed within the housing in a flow path between the inlet and the fluid outlet, and an air chamber in fluid communication with the air outlet. The disrupting element includes a protrusion extending across the flow path. The flow path includes a first cross-sectional flow area at the inlet, and a second cross-sectional flow area at the protrusion. The second cross-sectional flow area is smaller than the first cross-sectional flow area.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: December 22, 2020
    Assignee: AILNH, LLC
    Inventors: Norton Herrick, David Saloff, Richard Green
  • Publication number: 20200385800
    Abstract: Aspects of the present disclosure include methods of making barcoded solid supports. In some embodiments, the methods include producing a concatemer by rolling circle amplification (RCA) of a circular nucleic acid template, where the circular nucleic acid template includes a barcode and a stem-loop forming region, and where the concatemer includes a plurality of linked units, each unit including the barcode and a stem-loop structure formed from the stem-loop forming region. Such methods further include disposing the concatemer on a solid support to produce a barcoded solid support including a plurality of the stem-loop structures extending from the surface of the solid support. The methods may further include treating the stem-loop structures with an agent that produces stem structures having ends compatible with target nucleic acids, and attaching the target nucleic acids to the stem structures. Barcoded solid supports and methods of using the barcoded solid supports are also provided.
    Type: Application
    Filed: May 1, 2020
    Publication date: December 10, 2020
    Inventors: Richard Green, Balaji Sundararaman
  • Publication number: 20200326528
    Abstract: A telescope remote display and control system for viewing objects through a telescope and controlling the telescope remotely includes a wearable display, a manual controller, a camera, an mechanical adjuster, and an integration system, all of which are electrically interconnected. In the preferred embodiment, the camera, mechanical adjuster, and integration system are all attached to a target telescope and tripod assembly, while the wearable display and manual controller are positioned remotely. The integration system operates as the control hub, allowing a user to view images from the telescope with the wearable display by way of signals from the camera and control the positioning of the telescope with the manual controller through manipulation of the mechanical adjuster.
    Type: Application
    Filed: April 9, 2019
    Publication date: October 15, 2020
    Inventor: Richard Green
  • Patent number: 10795147
    Abstract: A telescope remote display and control system for viewing objects through a telescope and controlling the telescope remotely includes a wearable display, a manual controller, a camera, an mechanical adjuster, and an integration system, all of which are electrically interconnected. In the preferred embodiment, the camera, mechanical adjuster, and integration system are all attached to a target telescope and tripod assembly, while the wearable display and manual controller are positioned remotely. The integration system operates as the control hub, allowing a user to view images from the telescope with the wearable display by way of signals from the camera and control the positioning of the telescope with the manual controller through manipulation of the mechanical adjuster.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: October 6, 2020
    Inventor: Richard Green
  • Patent number: 10787667
    Abstract: Methods and compositions for modulating the activities of connexins are provided, including, for example, for use in post-surgical, trauma, or tissue engineering applications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated diseases and disorders where localized disruption in direct cell-cell communication is desirable.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: September 29, 2020
    Assignee: OCUNEXUS THERAPEUTICS, INC.
    Inventors: Wilda Laux, Colin Richard Green
  • Publication number: 20200288106
    Abstract: A telescope remote display and control system for viewing objects through a telescope and controlling the telescope remotely includes a wearable display, a manual controller, a camera, an mechanical adjuster, and an integration system, all of which are electrically interconnected. In the preferred embodiment, the camera, mechanical adjuster, and integration system are all attached to a target telescope and tripod assembly, while the wearable display and manual controller are positioned remotely. The integration system operates as the control hub, allowing a user to view images from the telescope with the wearable display by way of signals from the camera and control the positioning of the telescope with the manual controller through manipulation of the mechanical adjuster.
    Type: Application
    Filed: March 5, 2019
    Publication date: September 10, 2020
    Inventor: Richard Green
  • Publication number: 20200263175
    Abstract: The inventions relate to compositions and articles of manufacture comprising connexin modulators, pannexin modulators, gap junction modulators, hemichannel modulators, and pannexin channel modulators and their use, alone or in combination, in treating ocular and other disorders.
    Type: Application
    Filed: November 4, 2019
    Publication date: August 20, 2020
    Inventors: Colin Richard GREEN, Yeri KIM, Anthony PHILLIPS, Bradford James DUFT
  • Publication number: 20200239889
    Abstract: The inventions relate to compositions and articles of manufacture comprising connexin modulators, pannexin modulators, gap junction modulators, hemichannel modulators, and pannexin channel modulators and their use, alone or in combination, in treating ocular and other disorders.
    Type: Application
    Filed: November 4, 2019
    Publication date: July 30, 2020
    Inventors: Colin Richard GREEN, Yeri KIM, Anthony PHILLIPS, Bradford James DUFT
  • Patent number: D906512
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: December 29, 2020
    Assignee: AILNH, LLC
    Inventors: Norton Herrick, David Saloff, Richard Green